Abdul Mannan on Factor VIII Aurora: First Natural Gain-of-Function Mutation in Haemophilia A
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
“A fascinating case report on Factor VIII Aurora – the first ever natural gain-of-function mutation in Factor VIII!
This groundbreaking discovery from Aurora, Colorado reveals a novel mutation (p.Arg590Ser) that dramatically increases Factor VIII activity to 300-900% of normal and causes severe resistance to protein C regulation.
Just as Factor IX Padua revolutionised haemophilia B treatment, this natural ‘supercharged’ Factor VIII variant could transform future gene therapy approaches for haemophilia A.
The case highlights the importance of thorough investigation in young patients with unexplained thrombosis – sometimes the most puzzling cases lead to the most significant breakthroughs!”
Check here for more.
Read the full case here.
More insights on Hemostasis Today.
-
Mar 17, 2026, 18:11Ossama Mansour: Landmark MENA Guidelines for Acute Ischemic Stroke Management
-
Mar 17, 2026, 17:48Andrea Van Beek: Improving DOAC Adherence Saves Lives
-
Mar 17, 2026, 17:43Soumen Bhattacharyya: Microangiopathic Hemolytic Anemia Is Often a Hematologic Clue to Underlying Malignancy
-
Mar 17, 2026, 17:37Peter Bou Dib: New Insights on Factor VIII and the Musculoskeletal System
-
Mar 17, 2026, 17:31Armghan Ans: The 2026 Stroke Guidelines Are Excellent, Now the Hard Part
-
Mar 17, 2026, 17:26Danny Hsu: Navigating a Rebalanced Hemostatic State in Decompensated Cirrhosis
-
Mar 17, 2026, 17:21Matías J Alet on Acute Ischemic Stroke With Low NIHSS at NeuroQuality
-
Mar 17, 2026, 17:16S1PR4 Controls Platelet Fibrinogen Binding and Thrombus Formation – JTH
-
Mar 17, 2026, 15:55Mostafa Faisal Mohammed Saleh: Evidence-Based Recommendations for Hodgkin Lymphoma Management in LMICs